FCM IV iron introduction in Bihar - Implementation research
- Conditions
- Health Condition 1: D50- Iron deficiency anemia
- Registration Number
- CTRI/2023/11/059661
- Lead Sponsor
- Bill & Melinda Gates Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Pregnant women with a Hb level of 5–8.9 g/dL (moderate/severe anaemia) coming to the facility between gestational age of 15-34 weeks will be considered for FCM administration.
2.Immediate postnatal women with Hb level of 5–8.9 g/dL (moderate/severe anaemia).
3.Ratio of MCV to RBC count =13(Iron deficiency anaemia)
1.Have previously shown features of congestive heart failure (CHF) on the basis of history.
2.Known to be allergic to iron formulations. (From history)
3.Received any form of parenteral iron or blood transfusion during the current pregnancy. (from history)
4.Reported suffering from any chronic/systemic illness or blood disorders.
5.Postnatal women who took single dose IV FCM during her antenatal period. (from history and line list)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method